The Canadian Institute for Health Information reports that drug costs have grown from 8.4%
of total expenditures in the late 1970s to 14.5% in 1997. Meanwhile, spending for physician …

The prescription drug pricing provisions in the Inflation Reduction Act of 2022 constitute the
most transformative reform to the Medicare prescription drug benefit since its inception …

Rising drug costs are clearly a problem for Canadian public drug plans; Steven Morgan and
colleagues (May/June 03) are correct to point to the importance of comprehensive utilization …

Dramatic cost increases are driving the push to control pharmaceutical expenditures. Drug
costs in Canada have been rising more rapidly than other health care expenditures. Lost in …

This paper provides an update on trends in health care costs since 1999. Although the
growth rate in overall costs has been stable since 1999, the trend in costs for hospital …

Pharmaceuticals are a major part of health care in Canada. They represent one of the
largest and fastest growing components of health spending. Next year, Canadians will …

In response to concerns about the cost burden of medical care in general and rising
pharmaceutical costs in particular, a number of recent studies have examined trends in …

Drug spending hits $24.8 billion | CMAJ Skip to main content Main menu Home Content
Current issue Past issues Early releases Collections Sections Blog Infographics & illustrations …

T he pharmaceutical industry is in a period of growth, with increasing numbers of new drugs
being tested. More and more of these new entities are successfully completing clinical …

The recent editorial by Fox and Knoer1 about drug prices is very timely. High drug costs
continue to have a major impact on the delivery of affordable, quality healthcare in the …